Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,01 EUR | -.--% | -.--% | -.--% |
30/05 | NH TherAguix nomina Vincent Carrère come Amministratore Delegato | CI |
30/05 | NH TherAguix annuncia che AGuIX riceve la designazione Fast Track dalla Food and Drug Administration statunitense | CI |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Vincent Carrère
CEO | Chief Executive Officer | - | - |
Géraldine Le Duc
FOU | Founder | - | 11/12/15 |
Caroline Cayre
DFI | Director of Finance/CFO | - | 01/08/19 |
Markus Loeffler
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 63 | 22/02/19 | |
Marc Le Bozec
BRD | Director/Board Member | - | 22/02/19 |
Chairman | 62 | 22/02/19 | |
Director/Board Member | - | 22/02/19 | |
Célia Hart
BRD | Director/Board Member | - | 22/02/19 |
Thibaut Roulon
BRD | Director/Board Member | - | 22/02/19 |
Director/Board Member | 51 | 22/02/19 | |
Yannick Plétan
BRD | Director/Board Member | - | 22/02/19 |
Founder | - | 11/12/15 | |
Géraldine Le Duc
FOU | Founder | - | 11/12/15 |
Coordinate società
NH TherAguix SAS
29, chemin du Vieux Ch?ne Tarmac
38240, Meylan
+33 4 76 04 14 56
http://www.nhtheraguix.comSettore
- Borsa valori
- Azioni
- Azione ALNHT
- Società NH TherAguix SAS